Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

The Iran War Is Still Raging — So Why Can’t Investors Stop Buying?

by Team Lumida
6 days ago
Israel Strikes the Caspian: Hitting the Russia–Iran Weapons Smuggling Pipeline at Its Source

Hormuz is still shut, peace talks are stalled, and oil is near $100 — yet US stocks have roared back to all-time highs. A new investor psychology is...

Read more

Gold Is Down 10% Since the Iran War Began — Here’s Why the Safe-Haven Trade Isn’t Working

by Team Lumida
6 days ago
gold and silver round coins

Gold has lost around 10% since the Iran war started, bouncing back 0.8% to $4,755/oz Wednesday after Trump extended the ceasefire — but the metal faces twin headwinds:...

Read more

US Natural Gas Rises for a Fifth Straight Day — Carried Higher by Global Energy Contagion From the Iran War

by Team Lumida
6 days ago
brown metal tower

US natural gas futures settled up 0.3% to $2.697/mmbtu for a fifth consecutive gain, as Iran war fears lifted European gas and oil prices and triggered basket inflows...

Read more

Walmart Is Turning Its 4,600 Pharmacies Into a GLP-1 Powerhouse — With a New Digital Health Platform to Match

by Team Lumida
6 days ago
Walmart Expands Logistics Services Beyond Its Marketplace: What This Means for Investors

Walmart's Better Care Services platform now connects patients to third-party weight management providers who can prescribe GLP-1s, with Walmart handling prescription fulfillment — a bet that bundling coaching...

Read more

Wall Street Is Selling Hedge Fund-Style Quant Trading to Pension Funds and Endowments — And It’s Booming

by Team Lumida
6 days ago
Risk-Off Wave Hits Everything: Tech, Crypto, and Metals Unwind as Valuation Anxiety Spreads

Banks including JPMorgan, Goldman Sachs, and Morgan Stanley are racing to sell quantitative investment strategies to institutional and wealthy clients, with the market surging from $362B to $850B...

Read more

Tim Cook Is Stepping Down as Apple CEO — Hardware Chief John Ternus Takes Over September 1

by Team Lumida
6 days ago
Tim Cook Is Stepping Down as Apple CEO — Hardware Chief John Ternus Takes Over September 1

Apple announced that Tim Cook will step down as CEO on September 1, handing the reins to John Ternus, the 50-year-old head of hardware who led the company's...

Read more

China’s Netflix Says AI Will Make Most of Its Shows Within Five Years — and It’s Overhauling Everything to Get There

by Team Lumida
1 week ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

iQiyi CEO Gong Yu says AI will generate the bulk of the streamer's films and shows within five years, launching the Nadou Pro AI filmmaking suite and a...

Read more

Tesla Owners Are Suing — and Organizing Globally — Over Self-Driving Promises That Never Came True

by Team Lumida
1 week ago
blue coupe parked beside white wall

An 80-year-old retired attorney leads a California class action over Tesla's Full Self-Driving claims, as similar lawsuits emerge in Australia and a European campaign takes shape — putting...

Read more

The Traders Who Bought Bonds During the Iran War Are Being Vindicated — For Now

by Team Lumida
1 week ago
AI Job-Loss Panic Is Running Ahead of the Data, Says Bloomberg Opinion

Euro investment-grade bonds are heading for their best month in over a year and euro junk bonds their best since 2023, as credit investors who bought the war...

Read more

Nike Stock Hits Its Lowest Since 2014 — and Wall Street Is Asking If There’s Even a Turnaround

by Team Lumida
1 week ago
unpaired red Nike sneaker

Six brokers including JPMorgan, Goldman, and HSBC have abandoned bullish positions on Nike this month as the sneaker giant hemorrhages brand equity, market share, and market cap —...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Coinbase Eyes $2B BVNK Buy to Supercharge Stablecoin Payments

November 3, 2025
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

July 6, 2024
Nvidia’s AI Demand Surge: Hon Hai Ramps Up Server Production

Nvidia CEO Downplays AI Bubble Fears as He Enlists New Partners

October 29, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018